Routine care of peripheral intravenous catheters versus clinically indicated replacement: Randomised controlled trial

BMJ

Volumn 337, Issue 7662, 2008, Pages 157-160

  Webster, Joan ^a,b   Clarke, Samantha ^a   Paterson, Dana ^a   Hutton, Anne ^a   Van Dyk, Stacey ^a   Gale, Catherine ^a   Hopkins, Tracey ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INFECTION COMPLICATION; INTRAVENOUS CATHETER; MAJOR CLINICAL STUDY; PHLEBITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL PATIENT; TERTIARY HEALTH CARE; VEIN CATHETERIZATION;

EID: 47849106315     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.a339     Document Type: Article

References (15)

1. Bregenzer T, Conen D, Sakmann P, Widmer AF. Is routine replacement of peripheral intravenous catheters necessary? Arch Intern Med 1998;158:151-6.
2. Tripepi-Bova KA, Woods KD, Loach MC. A comparison of transparent polyurethane and dry gauze dressings for peripheral IV catheter sites: rates of phlebitis, infiltration, and dislodgment by patients. Am J Crit Care 1997;6:377-81.
3. Chee S, Tan W. Reducing infusion phlebitis in Singapore hospitals using extended life end-line filters. J Infus Nurs 2002;25:95-104.
4. Tager IB, Ginsberg MB, Ellis SE, Walsh NE, Dupont I, Simchen E, et al. An epidemiologic study of the risks associated with peripheral intravenous catheters. Am J Epidemiol 1983;118:839-51.
5. Martinez JA, Fernandez P, Rodriguez E, Sobrino J, Torres M, Nubiola A, et al. Intravenous cannulae: complications arising from their use and analysis of their predisposing factors. Med Clin (Barc) 1994;103:89-93.
6. Lipsky BA, Peugeot RL, Boyko EJ, Kent DL. A prospective study of Staphylococcus aureus nasal colonization and intravenous therapy-related phlebitis. Arch Intern Med 1992;152:2109-12.
7. White SA. Peripheral intravenous therapy-related phlebitis rates in an adult population. J Intraven Nurs 2001;24:19-24.
8. Shimandle RB, Johnson D, Baker M, Stotland N, Karrison T, Arnow PM. Safety of peripheral intravenous catheters in children. Infect Control Hosp Epidemiol 1999;20:736-40.
9. Cornely OA, Bethe U, Pauls R, Waldschmidt D. Peripheral Teflon catheters: factors determining incidence of phlebitis and duration of cannulation. Infect Control Hosp Epidemiol 2002;23:249-53.
10. Webster J, Lloyd S, Hopkins T, Osborne S, Yaxley M. Developing a research base for intravenous peripheral cannula re-sites (DRIP trial). A randomised controlled trial of hospital in-patients. Int J Nurs Stud 2007;44:664-71.
11. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines forthe prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002;23:759-69.
12. Wright A, Hecker J. Infusion failure caused by phlebitis and extravasation. Clin Pharm 1991;10:630-4.
13. Garland JS, Dunne WM Jr, Havens P, Hintermeyer M, Bozzette MA, Wincek J, et al. Peripheral intravenous catheter complications in critically ill children: a prospective study. Pediatrics 1992;89:1145-50.
14. Malach T, Jerassy Z, Rudensky B, Schlesinger Y, Broide E, Olsha O, et al. Prospective surveillance of phlebitis associated with peripheral intravenous catheters. Am J Infect Control 2006;34:308-12.
15. Nassaji-Zavareh M, Ghorbani R. Peripheral intravenous catheter-related phlebitis and related risk factors. Singapore Med J 2007;48:733-6.